ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
65,024.76
0.26%
S&P 500
5,667.20
0.64%
Dow Jones
40,954.48
1.85%
US Dollar vs Yen
158.38
0.15%
Brent Oil
83.235
-1.31%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. RespireRx Pharmaceuticals Inc (PK) (RSPI)

  7. RespireRx Pharmaceuticals Inc (PK) (RSPI) ニュース

RSPI

RespireRx Pharmaceuticals (PK) (RSPI)

RespireRx Pharmaceuticals Inc (PK)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:RSPI
日付受信時刻ニュースソース見出しコード企業名
2022/04/1603 : 17Edgar (US Regulatory)Annual Report (10-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2022/04/0422 : 22Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2022/04/0105 : 11Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2022/03/2905 : 06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2022/03/2321 : 31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2022/03/0722 : 16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2022/02/1207 : 25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2022/01/1106 : 32Edgar (US Regulatory)Reflects Information That Constitutes a Substantive Change From or Addition to the Information Set Forth in the Last Offering Circular (253g2)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2022/01/1022 : 31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2022/01/0322 : 30Edgar (US Regulatory)Reflects Information That Constitutes a Substantive Change From or Addition to the Information Set Forth in the Last Offering Circular (253g2)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2021/12/1506 : 13Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2021/12/0206 : 07Edgar (US Regulatory)Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2021/11/2223 : 05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2021/11/1522 : 31Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2021/11/0422 : 21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2021/10/1305 : 16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2021/09/2906 : 11Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2021/09/0322 : 16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2021/08/1705 : 05Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2021/08/0922 : 16Edgar (US Regulatory)Registration a Offering Under the Securities Act of 1933 (1-a)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2021/07/3105 : 12Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2021/07/0706 : 11Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2021/05/1805 : 24Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2021/05/1422 : 00Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2021/04/0105 : 06Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2021/02/2006 : 07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2021/02/2005 : 35Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2021/02/0906 : 06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/12/1423 : 10Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
2020/12/0200 : 01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
 Showing the most relevant articles for your search:USOTC:RSPI

最近閲覧した銘柄

NASDAQ
GOOGL
Alphabet
AMEX
XLE
Energy Select Sector SPDR
NYSE
JPM
JP Morgan Chase
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
ADDYY
Adidas (QX)
CCOM
US500
US 500
AMEX
SPY
SPDR S&P 500
CCOM
SILVER
SILVER
COIN
ETHUSD
Ethereum
USOTC
DTEGY
Deutsche Telekom (QX)
FX
USDGBP
US Dollar vs Sterling
NYSE
DIS
Walt Disney
FX
USDEUR
US Dollar vs Euro
NYSE
XOM
Exxon Mobil
FX
USDJPY
US Dollar vs Yen
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有